You have been chosen to receive this valuable information.
 
A SPECIAL
ANNOUNCEMENT FROM:
  BioPharm Logo  

View in browser
2018 PDA Endotoxins Workshop | October 17-18, 2018 | Bethesda, MD

Follow us:  

The 2018 PDA Endotoxins Workshop, Oct. 17-18, is rapidly approaching! Join us for two days of deep exploration into hot topics surrounding the evolution of endotoxin control and testing.

Immediately following the 13th Annual PDA Conference on Pharmaceutical Microbiology,, this Workshop will feature sessions led by industry and regulatory experts designed to provide you with scientific understanding and real-world best practices for endotoxin testing in bio/pharmaceutical production processes.

These are just some of the presentations you will hear:

  • rFC – From Genetic Engineering to Biomedical/Industrial Application in Endotoxin Detection | Lynne JL Ding, PhD, Professor, National University of Singapore
  • New Ways to Think About Depyrogenation | Karen Z. McCullough, MS, Principal Consultant, MMI Associates
  • Endotoxin in the Adaptive Immune Response | Kevin L. Williams, Senior Scientist, bioMérieux

Closely interact with your colleagues and peers during the Bacterial Endotoxin Testing and Data Integrity Breakout Sessions where you will analyze case studies and participate in small group discussions on gel clot, kinetic, and automated endotoxin testing platforms.

Members of PDA’s Low Endotoxin Recovery (LER) Task Force will also present an overview of the three main topics covered in the upcoming PDA Technical Report on the same subject, and will discuss a practical example of addressing LER in existing commercial products.

Explore the Future of Endotoxins Testing at the 2018 PDA Endotoxins Workshop and gain valuable insight to help you better manage and control endotoxin contamination.


Parenteral Drug Association (PDA)
4350 East West Highway, Suite 600
Bethesda, MD 20814 USA
Tel: +1 (301) 656-5900
Fax: +1 (301) 986-1093
www.pda.org
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of BioPharm International, a UBM publication. You are on the mailing list as %%emailaddress%%.